Multifocal atherosclerosis in patient after acute first degree radiation sickness.
Year: 2014, volume 10 Issue: №4 Pages: 862-867
Heading: radiation medicine Article type: Case report
Authors: Metlyaeva N.A., Lartsev M.A., Shcherbatykh O.V., Bushmanov A.Yu., Krasnyuk V.I.
Organization: State Scientific Research Center n.a. A.I. Burnasyan — Federal Medical Biophysical Center of Federal Medical Biological Agency
Heading: radiation medicine Article type: Case report
Authors: Metlyaeva N.A., Lartsev M.A., Shcherbatykh O.V., Bushmanov A.Yu., Krasnyuk V.I.
Organization: State Scientific Research Center n.a. A.I. Burnasyan — Federal Medical Biophysical Center of Federal Medical Biological Agency
Summary:
Purpose: assessment the heavy psychosomatic and all-somatic cardiovascular and cerebrovascular pathology of patient, transferred an acute I degree radiation sickness, from the general evenly gamma-beta radiation. Conclusions. The subdepressive and disturbing-depressive syndrome of patient, transferred an acute radiation sickness (ARS) of I degree, from the general evenly gamma-beta radiation, was independent risk factor of development of multifocal atherosclerosis; Features of development of all-somatic and psychosomatic pathology of patient are based on a combination of genetic prerequisites, environment influences (the stress caused by accident on the ChNPP) and social factors, influencing on him during a course of life, especially during early socialization. Thus at development of psychosomatic frustration the combination of feature of the mental reaction connected with the personal characteristic and special relationship between mental (stress) and physiological (somatic) by aspects of reaction which led to metabolism violation, to aging, decrease in adaptation opportunities of an organism and development age — dependent pathology took place.
Keywords: acute radiation disease, adaptation, atherosclerosis, cerebrovascular arteriosclerosis, hypertensive disease, ionizing radiation, ischemic heart disease, obliterating endoangiitis
Bibliography:
1. Moskalev Al. Genetics and epigenetics of aging and longevity. In: Collect, of works of the 3rd International conference, 2014; p. 5-9
2. Balukova EV, Uspenski YuP, Tkachenko El. Anxiety disorders in patients with therapeutic profile. Ter arch 2007; 79 (6): 85-88
3. Nedostup AV, Fedorova VI, Solov'eva AD, et al. Psycho-vegetative ratio of cardiology and the importance of their correct medication. Ter arch 2007; 79 (1): 68-73
4. Kirichenko АА, Eabzeeva EYu. The role of depressive disorders with hypertensive illness and possibilities of their correction: evaluation of the effect of tianeptine. Cardiology 2002; 10 (10): 36-40
5. Didigova РТ, Bulgucheva ZZ, Ugurchieva ZO, et al. Detection of anxiety and depression in a cohort of men and women, suffering from coronary heart disease. Prophylact med 2012; 15 (1): 61-64
6. Garganeeva NP The new strategy of multifactori-al prevention of cardiovascular disease in patients with anxiety and depressive disorders in terms of psychosocial stress. Rus med journ Cardiology 2008; 26 (16): 1-8
7. Medvedev VE. Therapy of anxiety disorders in patients with cardiovascular diseases (the experience of Afobazole application). Arch inside med 2013; 3 (11): 54-60
8. Bobir' MA. Clinical-epidemiological aspects of the prevalence of symptoms of anxiety, anxiety and depression in patients with arterial hypertension: PhD abstract. M., 2007; 24 p.
9. Mosolov SN. Disturbing and depressive disorders: comorbidity and treatment. M., 2009; 63 p.
10. Ibatov AD. The impact of disturbing disorders on the course of ischemic heart disease. Rus med journ Cardiology 2007; 15 (20): 1-4
11. Oganov RG, Pogosova GV, Schal'nova SA. Depressive disorders in general medical practice according to COMPAS research: the cardiologist look. Cardiology 2005; 8: 37-43
12. Kozlova SN, Krylova YuS, Schyachto EV, et al. The prognosis of patients with ischemic heart disease with comorbid anxiety and depressive disorders: results of a prospective four-year follow-up. Review of psychiat and med psychol. 2012; (4): 44-48
13. Gafarov VV, Gromova ЕА, Gagulin IV, Gafarova AV. Eight-year study of the effect of depression on the risk of myo-cardial infarction in men aged 25-64 (epidemiological study on the basis of the program VOZ «MONIKA»). Ter arch 2005; 77 (9): 60-64
14. Chazov El, Oganov RG, Pogosova GV, et al. Clinical-epidemiological study program of depression in cardialogi-cal practice: in patients with arterial hypertension and ischemic heart disease (COORDINATA): results of a multicenter study. Cardiology 2007; 55: 1-9
15. Vasyuk YuA, Dovzhenko TV. Diagnosis and treatment of depression in diseases of the cardiovascular system. M., 2006; 58 p.
16. Smulevich АВ, Dubnizkaya ЕаВ, Drobizhev MYu. Depressions and opportunities of their treatment in general medical practice (preliminary results of the program SAIL). Mental disorders in the total med 2007; 2 (2): 33-39
17. Luk'yanchikova VF, Ostrovski АВ. Correction of heart rate variability in patients with ischemic heart disease with depressive disorders in the treatment of fevarin. Cardiovasc ter and prophylact 2007; 6 (5): 185 p.
18. Borovkov N, Berdnikova L, Dobrotina I. On the treatment of disturbing and depressive disorders in patients with cardiovascular disease. Doctor: monthly scientific and practical journal 2013; (12): 53-58
19. Akberov RF. Ultrasound technology in the diagnosis of multifocal atherosclerosis. Cardiology: monthly scientific journal 2008; 144 p.
20. Karetnikova VT, Belen'kova YuA, Ziekov MV, et al. Multifocal atherosclerosis as a factor of poor prognosis in patients with myocardial infarction with ST-segment elevation and diabetes of the 2nd type. Cardiology: monthly scientific journal 2013; 53 (4): 12-17
21. Yachno NN, Schtul'man DR. Diseases of the nervous system: a guide for physicians. Cardiology: monthly scientific-practice journal 2013; Medicine 2004; 1: 231-302
22. Schishkova VN, Zotova LI, Fukalov YuA, Schklovs-ki VM. The problem of cerebrovascular complications in patients with high risk for cardiovascular disease: focus on diabetes. Cardiology: monthly scientific journal 2013; 53:
52-57
23. Hautefeuille A, Jeffredo Р, Cadier S, et al. Home blood pressure measurement: source of anxiety? Prospective observation study. Rev Prat 2009; 20 (59): 3-6
24. Nabi H, Chastang JF, Lefevre T, et al. Trajectories of depressive episodes and hypertension over 24 years: the Whitehall II prospective cohort study. Hypertension 2011; 57: 710-716
25. Patten S, Williams JV, Lavorato DH, et al. Major depression as a risk factor for high blood pressure: epidemiologic evidence from a national longiturdinal study. Psychosom med 2009; 71 (3): 273-279
26. Brown ES, Varghese FP, McEwen BS. Association of depression with medical illness; does cortisol play a role? Biol Psychiatry 2004; 55(1): 1-9
27. Lambert E, Dawood T, Straznicky N, et al. Association between the sympathetic firing pattern and anxiety level in patients with the metabolic syndrome and elevated blood pressure. J Hypertens 2010; 28 (3): 543-550
28. Empana J, Sykes DH, Luc G, et al. Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the prospective epid emiological study of myocardial infarction (PRIME). Circulation 2005; 111:2299-2305
29. Kim L, Lavoie K, Arsenault A, et al. Association between Clinical Depression and Endothelial Function Measured by Forearm Hyperemic Reactivity. Psychosomatic med 2010; 72 (1): 20-26
30. Vreede J, Gorgels A, Vestraaten G. Did prognosis after myocardial infarction change during the past 30 year? A me-ta-analysis. J Am Coll Cardiol 1991; 18: 698-706.
| Attachment | Size |
|---|---|
| 2014_04-01_862-867.pdf | 298.77 KB |
Русский
English